2Scher PK.Onychomycosis a significant medical disorder[J].J Am Acad Dermatol,1996,35(3 Pt 2):S2.
3Gupta AK.Phamacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in theUnited State[J].J Am Avad Dermatol,2000,43(4 suppl):S81.
4[2]Sigurgeirsson B,Steingrimsson O,Svein-sdottir S.Prevalence of onychomycosis in Iceland:a population-based study.Acta Derm Venereol,2002,82 (6):467-469
6[4]Ghannoum MA,Hajjeh RA,Scher H,et al.A large-scale American study of funfal isolates from nails:the frequency of onychomycosis,fungal distribution,and antifungal susceptibility patterns.J Am Acad Dermatol,2000,43(4):641-648
7[5]Gupta AK,Sibbald G,Lynde CW,et al.Onychomycosis in children:prevalence and treatment strategies.J Am Acad Dermatol,1997,36(3 Pt 1):395-402
8[6]Gupta AK,Jain HC,Lynde CW,et al.Prevalence and epidemiology of onychomycosis in patients visiting physicians offices:a multicenter Canadian survey of 15,000 patients.J Am Acad Dermatol,2000,43 (2Pt1):244-248
9[7]Gupta AK,Jain HC,Lynde CW,et al.Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists'offices in Ontario,Canada:a multicenter survey of 2001 patients.Int J Dermatol,1997,36(10):783-787
10[9]Gupta AK.Onychomycosis in the elderly.Drugs Aging,2000,16(6):397-407
